Citation

Benchekroun M, Romero A, Egea J, León R, Michalska P, Buendía I, Buendía I, Jimeno ML, Jun D, Janockova J, Sepsova V, Soukup O, Bautista-Aguilera OM, Refouvelet B, Ouari O, Marco-Contelles J, Ismaili L.: The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. J Med Chem, Volume 59 (21), 2016

Authors

Bautista-Aguilera OM, Benchekroun M, Buendía I, Egea J, Ismaili L., Janockova J, Jimeno ML, Jun D, León R, Marco-Contelles J, Michalska P, Ouari O, Refouvelet B, Romero A, Sepsova V, Soukup O

Journal

J Med Chem

Year

2016

DOI

10.1021/acs.jmedchem.6b01178

PubMed

27736061

Machine-readable

REST APIRDF